Publicacións en colaboración con investigadores/as de German Center for Neurodegenerative Diseases (36)

2024

  1. Aggregation-resistant alpha-synuclein tetramers are reduced in the blood of Parkinson’s patients

    EMBO Molecular Medicine, Vol. 16, Núm. 7, pp. 1657-1674

  2. Neuroimaging biomarkers in the biological definition of Parkinson’s disease and dementia with Lewy bodies – EANM position on current state, unmet needs and future perspectives

    European Journal of Nuclear Medicine and Molecular Imaging

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. EANM position paper: theranostics in brain tumours—the present and the future

    European Journal of Nuclear Medicine and Molecular Imaging

  3. Erratum: Author Correction: Common variants in Alzheimer's disease and risk stratification by polygenic risk scores (Nature communications (2021) 12 1 (3417))

    Nature communications

  4. Estradiol regulates leptin sensitivity to control feeding via hypothalamic Cited1

    Cell Metabolism, Vol. 35, Núm. 3, pp. 438-455.e7

  5. Mendelian Randomisation Confirms the Role of Y-Chromosome Loss in Alzheimer’s Disease Aetiopathogenesis in Men

    International Journal of Molecular Sciences, Vol. 24, Núm. 2

  6. MiRNA Differences Related to Treatment-Resistant Schizophrenia

    International Journal of Molecular Sciences, Vol. 24, Núm. 3

2022

  1. Endogenous Levels of Alpha-Synuclein Modulate Seeding and Aggregation in Cultured Cells

    Molecular Neurobiology, Vol. 59, Núm. 2, pp. 1273-1284

  2. Genome-wide meta-analysis for Alzheimer’s disease cerebrospinal fluid biomarkers

    Acta Neuropathologica, Vol. 144, Núm. 5, pp. 821-842

  3. Glycation modulates alpha-synuclein fibrillization kinetics: A sweet spot for inhibition

    Journal of Biological Chemistry, Vol. 298, Núm. 5

  4. New insights into the genetic etiology of Alzheimer's disease and related dementias

    Nature genetics, Vol. 54, Núm. 4, pp. 412-436

  5. Publisher Correction: Stroke genetics informs drug discovery and risk prediction across ancestries (Nature, (2022), 611, 7934, (115-123), 10.1038/s41586-022-05165-3)

    Nature

  6. Stroke genetics informs drug discovery and risk prediction across ancestries

    Nature, Vol. 611, Núm. 7934, pp. 115-123

2021

  1. Celia’s encephalopathy (Bscl2-gene-related): Current understanding

    Journal of Clinical Medicine, Vol. 10, Núm. 7

  2. Common variants in Alzheimer's disease and risk stratification by polygenic risk scores

    Nature communications, Vol. 12, Núm. 1, pp. 3417

  3. Doxycycline Interferes With Tau Aggregation and Reduces Its Neuronal Toxicity

    Frontiers in Aging Neuroscience, Vol. 13

2020

  1. Effects of pharmacological modulators of α-synuclein and tau aggregation and internalization

    Scientific Reports, Vol. 10, Núm. 1

  2. Identification of novel risk loci and causal insights for sporadic Creutzfeldt-Jakob disease: a genome-wide association study

    The Lancet Neurology, Vol. 19, Núm. 10, pp. 840-848

  3. Intravenous alteplase for stroke with unknown time of onset guided by advanced imaging: systematic review and meta-analysis of individual patient data

    The Lancet, Vol. 396, Núm. 10262, pp. 1574-1584